Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Pain Palliat Care Pharmacother ; 33(1-2): 49-53, 2019.
Article in English | MEDLINE | ID: mdl-31465697

ABSTRACT

A 51-year-old man with metastatic renal cell carcinoma whose fentanyl requirement was 3000-4000 µg/h in inpatient hospice presented for a thoracic (T) vertebral 4-10 posterior spinal fusion for a lytic T7 compression fracture. He underwent total intravenous (IV) anesthesia with propofol, remifentanil, and ketamine; liposome bupivacaine was locally infiltrated at the end of the case. Following extubation on postoperative day (POD) 1, he had severe pain refractory to high-dose IV fentanyl patient control analgesia and ketamine infusion. His pain dramatically improved after a dexmedetomidine infusion was added and titrated to the analgesic effect. He participated in neurological examinations and fulfilled both surgical and pain management goals without side effects. Dexmedetomidine was successfully weaned off on POD 3.


Subject(s)
Analgesics, Non-Narcotic/administration & dosage , Analgesics, Opioid/administration & dosage , Dexmedetomidine/administration & dosage , Pain, Postoperative/drug therapy , Anesthetics, Intravenous/administration & dosage , Carcinoma, Renal Cell/pathology , Drug Tolerance , Fentanyl/administration & dosage , Humans , Kidney Neoplasms/pathology , Male , Middle Aged , Spinal Fusion/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...